Remodelling the upper eyelid in the management of orbitopalpebral neurofibromatosis

Daniel Marchac, Jonathan A. Britto
{"title":"Remodelling the upper eyelid in the management of orbitopalpebral neurofibromatosis","authors":"Daniel Marchac,&nbsp;Jonathan A. Britto","doi":"10.1016/j.bjps.2005.04.019","DOIUrl":null,"url":null,"abstract":"<div><p>Neurofibromatosis of the orbitopalpebral complex is a debilitating disease. The development of safe craniofacial surgical technique has greatly improved outcome in the surgical palliation of this progressive condition, and various centres have reported their experience. Extensive upper eyelid neurofibroma creates a functional and aesthetic problem, which is inadequately addressed in the literature. The experience of the senior author (DM) representing the treatment of 27 such patients is currently reported. The stigmata of eyelid neurofibromatosis were scored retrospectively by a novel scale applied to standardised photographs at patient presentation. A numeric severity score was given to each of: upper eyelid ptosis, canthal malposition, and oculo-palpebral diastasis. Disease progression and post-operative result were similarly scored at various stages follow-up photography. All patients underwent a full thickness, transverse or transverse-oblique resection of upper eyelid disease, with immediate levator reconstruction and canthopexies as necessary. A mean improvement of 3.33 points was achieved in the majority of patients (median one operation per patient; mean 1.5, range 1–3). Secondary eyelid procedures (<em>n</em>=9 pts) represented tumour debulking, canthopexy, or procedures to deepen the fornix in patients with prostheses. This series demonstrates that a tailored, often radical palpebral remodelling in orbitopalpebral neurofibromatosis may provide functional and aesthetic benefit.</p></div>","PeriodicalId":9252,"journal":{"name":"British journal of plastic surgery","volume":"58 7","pages":"Pages 944-956"},"PeriodicalIF":0.0000,"publicationDate":"2005-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bjps.2005.04.019","citationCount":"31","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British journal of plastic surgery","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0007122605001293","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 31

Abstract

Neurofibromatosis of the orbitopalpebral complex is a debilitating disease. The development of safe craniofacial surgical technique has greatly improved outcome in the surgical palliation of this progressive condition, and various centres have reported their experience. Extensive upper eyelid neurofibroma creates a functional and aesthetic problem, which is inadequately addressed in the literature. The experience of the senior author (DM) representing the treatment of 27 such patients is currently reported. The stigmata of eyelid neurofibromatosis were scored retrospectively by a novel scale applied to standardised photographs at patient presentation. A numeric severity score was given to each of: upper eyelid ptosis, canthal malposition, and oculo-palpebral diastasis. Disease progression and post-operative result were similarly scored at various stages follow-up photography. All patients underwent a full thickness, transverse or transverse-oblique resection of upper eyelid disease, with immediate levator reconstruction and canthopexies as necessary. A mean improvement of 3.33 points was achieved in the majority of patients (median one operation per patient; mean 1.5, range 1–3). Secondary eyelid procedures (n=9 pts) represented tumour debulking, canthopexy, or procedures to deepen the fornix in patients with prostheses. This series demonstrates that a tailored, often radical palpebral remodelling in orbitopalpebral neurofibromatosis may provide functional and aesthetic benefit.

眶睑神经纤维瘤病的上睑重塑治疗
眶睑复合体神经纤维瘤病是一种使人衰弱的疾病。安全颅面外科技术的发展极大地改善了手术缓解这种进展性疾病的结果,各个中心都报告了他们的经验。广泛的上眼睑神经纤维瘤造成功能和美学问题,这是在文献中没有充分解决。目前报告了代表27例此类患者的资深作者(DM)的治疗经验。眼睑神经纤维瘤病的污斑是回顾性评分的一种新的尺度应用于标准化的照片,在病人的表现。对上睑下垂、眦错位和眼-睑裂进行数值严重程度评分。在随访摄影的不同阶段,疾病进展和术后结果评分相似。所有患者均行上睑病变全层、横向或横向斜切术,必要时立即行提上睑肌重建和眦固定术。大多数患者的平均改善为3.33分(平均每位患者一次手术;平均值1.5,范围1-3)。二次眼睑手术(n=9例)代表假体患者的肿瘤缩小、眦固定术或穹窿加深手术。这一系列的研究表明,在眼眶眼睑神经纤维瘤病中,量身定制的、通常是根治性的眼睑重塑可能提供功能和美学上的好处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信